National Antibiotic Allergy Network (NAAN)
The National Antibiotic Allergy Network (NAAN) is a collaborative group of mixed discipline clinicians and policy makers related to antibiotic allergy.
The NAAN provides a repository of consumer and clinician antibiotic allergy protocols, policies and procedures, that can be disseminated and implemented nationally, in particular to aid sites with limited resources or experience with antibiotic allergy.
Visit the NAAN website for further information.
Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR)
Predictors, Immunopathogenesis and Prescribing in Antibiotic allergy (PIPA)
A multicentre prospective cohort study of antibiotic allergy. The study commenced in 2015 at Austin Health, Peter MacCallum Cancer Centre and Alfred Health examining the impacts of antibiotic allergy testing on prescribing. Further, the study has ongoing recruitment of patients with severe delayed antibiotic hypersensitivities to collect blood for the development of novel diagnostics (IFN-y release Enzyme Linked ImmunoSpot Assay), immune profiling and pharmacogenomic assessment.
Visit the PIPA website for further information.
Randomised Control Trials (Antibiotic Allergy)
A multicentre phase III study of oral penicillin allergy challenge in the outpatient setting.
A pilot randomised control trial of oral penicillin challenge in the Intensive Care Unit (ICU).
A multicentre pilot randomised control trial of oral beta-lactam challenge in the perioperative setting.
Professor Jason Trubiano
+61 3 94966676 | firstname.lastname@example.org
Professor Trubiano is an Infectious Diseases Physician and Director of Infectious Diseases at Austin Health. He is an NHMRC Emerging Leadership Fellow at the University of Melbourne, Department of Infectious Diseases. He is the laboratory head for the Centre for Antibiotic Allergy and Research (Austin Health) and his research explores health services programs for antibiotic allergy and novel diagnostics and pharmacogenomic predictors for severe T-cell mediated drug reactions.